Cutaneous manifestations in neurofibromatosis type 1

被引:36
|
作者
Miraglia, E. [1 ]
Moliterni, E. [1 ]
Lacovino, C. [1 ]
Roberti, V [1 ]
Laghi, A. [1 ]
Moramarco, A. [2 ]
Giustini, S. [1 ]
机构
[1] Sapienza Univ Rome, Dermatol Clin, Rome, Italy
[2] Sapienza Univ Rome, Dept Sense Organs, Rome, Italy
来源
CLINICA TERAPEUTICA | 2020年 / 171卷 / 05期
关键词
Cafe-au-lait macules; cutaneous manifestations; freckling; neurofibromatosis type 1; neurofibroma; neurofibromin; RETINAL MICROVASCULAR ABNORMALITIES; AU LAIT MACULES; POLIOSIS CIRCUMSCRIPTA; BECKERS NEVUS; IN-VIVO; NF1; PATIENT; ASSOCIATION; EXPERIENCE; SPOTS;
D O I
10.7417/CT.2020.2242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To better understand the real prevalence of cutaneous manifestations, in Neurofibromatosis type 1. Materials and Methods. We reviewed all clinical charts of 1102 NF1 patients followed by February 1983 to February 2020 at the "Sapienza" University of Rome, Italy. NF1 patients are seen usually every year by a dermatologist. Results. Cafe-au-lait macules were shown in 1063 patients (96.5%), axillary and inguinal freckling in 991 (90%) and neurofibromas in 861 (78.1%). Other skin manifestations included: lipoma (6.2%), nevus anemicus (3.9%), psoriasis (3.4%), spilus nevus (3.2%), juvenile xanthogranuloma ( 3.2%), vitiligo (2.3%), Becker's nevus (1.9%), melanoma (0.7%) and poliosis (0.5%). Conclusions. Neurofibromatosis type 1 is a multisystem disorder primarily involving the skin and nervous system. The clinical manifestations are extremely variable even within a family. This study was performed to delineate the prevalence of cutaneous manifestations in NF1.
引用
收藏
页码:E371 / E377
页数:7
相关论文
共 50 条
  • [1] Cutaneous Findings in Neurofibromatosis Type 1
    Ozarslan, Bengisu
    Russo, Teresa
    Argenziano, Giuseppe
    Santoro, Claudia
    Piccolo, Vincenzo
    CANCERS, 2021, 13 (03) : 1 - 17
  • [2] Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study
    Garcia-Martinez, F. J.
    Duat-Rodriguez, A.
    Esteban, E. Andres
    Torrelo, A.
    Morel, L. Noguera
    Hernandez-Martin, A.
    ACTAS DERMO-SIFILIOGRAFICAS, 2022, 113 (10): : 923 - 929
  • [3] Spinal manifestations of Neurofibromatosis type 1
    Shofty, Ben
    Barzilai, Ori
    Khashan, Morsi
    Lidar, Zvi
    Constantini, Shlomi
    CHILDS NERVOUS SYSTEM, 2020, 36 (10) : 2401 - 2408
  • [4] Spinal manifestations of Neurofibromatosis type 1
    Ben Shofty
    Ori Barzilai
    Morsi Khashan
    Zvi Lidar
    Shlomi Constantini
    Child's Nervous System, 2020, 36 : 2401 - 2408
  • [5] Neurofibromatosis Type 1: Exuberant Cutaneous Involvement
    Ferreira, Sandra
    Selores, Manuela
    Torres, Tiago
    ACTA MEDICA PORTUGUESA, 2020, 33 (02): : 149 - 149
  • [6] Pigment cell-related manifestations in neurofibromatosis type 1: an overview
    Schepper, SD
    Boucneau, J
    Lambert, J
    Messiaen, L
    Naeyaert, JM
    PIGMENT CELL RESEARCH, 2005, 18 (01): : 13 - 24
  • [7] Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments
    Poplausky, Dina
    Young, Jade N. N.
    Tai, Hansen
    Rivera-Oyola, Ryan
    Gulati, Nicholas
    Brown, Rebecca M. M.
    CANCERS, 2023, 15 (10)
  • [8] Musculoskeletal Manifestations of Neurofibromatosis Type 1: a Pictorial Review
    Ip, N. S. K.
    Lee, C. Y.
    Yuen, M. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2018, 21 (03): : 213 - 221
  • [9] An update on the CNS manifestations of neurofibromatosis type 2
    Coy, Shannon
    Rashid, Rumana
    Stemmer-Rachamimov, Anat
    Santagata, Sandro
    ACTA NEUROPATHOLOGICA, 2020, 139 (04) : 643 - 665
  • [10] An update on the central nervous system manifestations of neurofibromatosis type 1
    Nix, J. Stephen
    Blakeley, Jaishri
    Rodriguez, Fausto J.
    ACTA NEUROPATHOLOGICA, 2020, 139 (04) : 625 - 641